Other benign neoplasms of uterus
Chapter 2:Neoplasms
ICD-10 D26 is a billable code used to indicate a diagnosis of other benign neoplasms of uterus.
D26 refers to other benign neoplasms of the uterus, which encompasses a variety of non-cancerous growths that can occur in the uterine tissue. These neoplasms may include uterine fibroids (leiomyomas), adenomyomas, and other less common benign tumors. While many benign neoplasms are asymptomatic, they can sometimes lead to symptoms such as abnormal uterine bleeding, pelvic pain, or pressure symptoms depending on their size and location. Diagnosis typically involves imaging studies such as ultrasound or MRI, and in some cases, a biopsy may be performed to rule out malignancy. Management options vary based on the size, symptoms, and patient preferences, ranging from watchful waiting to medical management with hormonal therapies, or surgical interventions such as myomectomy or hysterectomy. Follow-up care is essential to monitor for any changes in the neoplasm or the emergence of new symptoms, ensuring that any potential complications are addressed promptly.
Detailed documentation of patient history, physical examination findings, imaging results, and treatment plans.
Management of symptomatic fibroids, evaluation of abnormal uterine bleeding, and pre-operative assessments.
Ensure accurate coding of the specific type of neoplasm and any associated symptoms or complications.
Clear imaging reports that specify the characteristics of the neoplasm and any recommendations for further management.
Ultrasound or MRI evaluations for suspected uterine neoplasms.
Radiologists should provide detailed descriptions to aid in accurate coding and management decisions.
Used when a patient with benign neoplasms requires surgical intervention.
Operative report detailing the procedure and indication for surgery.
Obstetricians should ensure that the diagnosis supports the need for surgery.
D26 includes various benign neoplasms such as uterine fibroids, adenomyomas, and other non-cancerous growths of the uterus.
Documentation should clearly state the diagnosis, and any imaging or biopsy results should be included to support the benign classification.
